8th Circ. Revives DOD Fraud Claims In Bayer FCA Suit

Law360, New York (October 15, 2013, 3:25 PM ET) -- The Eighth Circuit on Tuesday revived a False Claims Act suit alleging Bayer AG misled the U.S. Department of Defense about the risks of its now-defunct cholesterol-lowering drug Baycol, finding the DOD allegations were properly brought under the fraud-in-the-inducement theory.

A divided panel for the appeals court held that former Bayer senior market research analyst Laurie Simpson's accusations that Bayer fraudulently induced the DOD to enter into a roughly $11.9 million contract extension for the purchase of Baycol sufficiently identified the “who, what, where, when and...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers

Required